| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.0B | $3.4B | $3.7B | $3.9B | $4.1B | $4.2B | $4.5B | $6.0B |
| Cost of Revenue | $2.5B | $2.7B | $2.9B | $3.0B | $3.1B | $3.2B | $3.5B | — |
| Gross Profit | — | — | — | — | — | — | — | $1.0B |
| R&D Expense | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | $0.4B | $0.5B | $0.5B | $0.4B | $0.5B | $0.5B | $0.5B | $0.6B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $-0.2B | $0.4B | $-0.3B | $-0.2B | $-0.0B | $-0.1B | $-1.9B | $0.2B |
| EPS (Basic) | $-1.14 | $2.28 | $-1.41 | $-0.89 | $-0.18 | $-0.61 | $-9.29 | $0.84 |
| EPS (Diluted) | $-1.14 | $2.23 | $-1.41 | $-0.89 | $-0.18 | $-0.61 | $-9.29 | $0.83 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.4B | $2.6B | $3.2B | $3.6B | $4.0B | $4.3B | $4.5B | $7.5B |
| Current Assets | $1.1B | $1.3B | $1.7B | $1.6B | $1.7B | $1.6B | $1.6B | $2.7B |
| Cash & Equivalents | $0.2B | $0.4B | $0.5B | $0.6B | $0.4B | $0.5B | $0.5B | $0.7B |
| Total Liabilities | $1.6B | $1.6B | $2.4B | $2.5B | $2.8B | $2.9B | $3.1B | $3.9B |
| Current Liabilities | $0.7B | $0.7B | $0.9B | $0.9B | $1.0B | $1.1B | $1.2B | $1.4B |
| Stockholders' Equity | $0.7B | $0.8B | $0.6B | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.1B | $-0.1B | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B | — |
| Investing Cash Flow | $-0.0B | $0.8B | $-0.1B | $0.2B | $-0.1B | $-0.1B | $-0.3B | — |
| Capital Expenditures | $0.1B | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.0B | $-0.9B | $-0.1B | $-0.1B | $-0.1B | $-0.1B | $-0.1B | — |